Your browser doesn't support javascript.
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
Kemmner, Stephan; Guba, Markus O; Schönermarck, Ulf; Stangl, Manfred; Fischereder, Michael.
  • Kemmner S; Transplant Center, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany. Electronic address: stephan.kemmner@med.uni-muenchen.de.
  • Guba MO; Department of General, Visceral, and Transplant Surgery, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
  • Schönermarck U; Renal Division, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
  • Stangl M; Department of General, Visceral, and Transplant Surgery, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
  • Fischereder M; Renal Division, Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians University (LMU), Munich, Germany.
Kidney Int ; 98(2): 507-508, 2020 08.
Article in English | MEDLINE | ID: covidwho-526802
Semantic information from SemMedBD (by NLM)
1. cyclosporine TREATS Recipient
Subject
cyclosporine
Predicate
TREATS
Object
Recipient
2. cyclosporine TREATS Recipient
Subject
cyclosporine
Predicate
TREATS
Object
Recipient

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Pneumonia, Viral / Kidney Transplantation / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics Limits: Humans Language: English Journal: Kidney Int Year: 2020 Document Type: Article

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Pneumonia, Viral / Kidney Transplantation / Coronavirus Infections / Severe Acute Respiratory Syndrome / Pandemics Limits: Humans Language: English Journal: Kidney Int Year: 2020 Document Type: Article